This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $1,270.30 delivery order contract is for the supply of Quillivant XR 25 mg/5 ml suspension, a specialty medication. The contract has a firm fixed price and an ultimate completion date of October 18, 2024.
AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also has a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for federal healthcare beneficiaries. The contract award reviewed did not have a set-aside designation, indicating open competition.
Generated 1/16/25, 9:11 AM